Search
Search Results
-
Impact of sex on response to BCG in non-muscle invasive bladder cancer patients: a contemporary review from a tertiary care center
PurposeFemale sex has been implicated with higher stage at diagnosis and as a negative prognostic factor amongst patients with non-muscle invasive...
-
Intravesical Pseudomonas aeruginosa mannose-sensitive Hemagglutinin vaccine triggers a tumor-preventing immune environment in an orthotopic mouse bladder cancer model
Bacillus Calmette-Guerin (BCG) immunotherapy can prevent recurrence and progression in selected patients with non-muscle-invasive bladder cancer...
-
Can random bladder biopsies be eliminated after bacillus Calmette–Guérin therapy against carcinoma in situ?
PurposeIntravesical bacillus Calmette–Guérin (BCG) is the standard of care for bladder carcinoma in situ (CIS). The response to BCG therapy against...
-
CACA guidelines for holistic integrative management of urothelial carcinoma
Bladder urothelial carcinoma (UC) is the most common malignant tumor of the urinary system. It has the characteristics of high recurrence rate and...
-
-
Prevention of local symptoms in muscle invasive bladder cancer patients: clinical significance of local radiation therapy
PurposeTo evaluate the significance of local radiation therapy (LRT) for prevention of local symptoms (LSs) caused by muscle-invasive bladder cancer...